Share:
Peer-Reviewed Publication
Front Radiol2026;61667306.January 1, 2026Journal Article

MRI approach to the patient with suspected dementia: artificial intelligence techniques and semi-quantitative rating scales compared.

S F Calloni1, A Diena1, G M Agazzi1, M Zavarella2, P Q Vezzulli1, G Cecchetti2,3,4, E G Spinelli3,4,5, G Rugarli2,4,5, A Ghirelli2,4,5, G Magnani6, F Caso6, A van Loon7, F Agosta4,5,6,8, M Filippi2,3,4,5,6,8,9, A Falini1,4
1Neuroradiology Unit and Cermac, IRCCS Ospedale San Raffaele, Milan, Italy.
2Center for Alzheimer's Disease and Related Disorders (CARD), Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
3Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.
4Vita-Salute San Raffaele University, Milan, Italy.
5Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
6Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
7DeepHealth, Boston, MA, United States.
8Neurotech Hub, Vita-Salute San Raffaele University, Milan, Italy.
9Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Abstract

OBJECTIVES: To assess the reliability of semi-quantitative and AI-based quantitative brain volume evaluation (Quantib® ND) in predicting clinical diagnosis in patients with suspected neurodegenerative diseases undergoing initial 1.5 T MRI. Additionally, to analyze the frequency of lobar microbleeds (MBs) at diagnosis. METHODS: Two neuroradiologists (2 vs. 10 years' experience), blinded to diagnos…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.